Literature DB >> 12441077

Chimeric ecotropic MLV envelope proteins that carry EGF receptor-specific ligands and the Pseudomonas exotoxin A translocation domain to target gene transfer to human cancer cells.

Otto Erlwein1, Winfried Wels, Barbara S Schnierle.   

Abstract

Redirecting retroviral vector transduction simply by insertion of a ligand into the envelope (Env) protein has met with several obstacles. For example, virions targeted to epidermal growth factor receptor (EGFR), after receptor binding, rapidly traffic to the lysosomes, where they are degraded. Exotoxin A of Pseudomonas aeruginosa has the ability to translocate from endosomes to the cytoplasm by means of a translocation domain (TLD). We generated a series of chimeric Env proteins of Moloney murine leukemia virus containing EGFR ligands, where TLD was inserted into different regions. These chimeric proteins were successfully produced, if the translocation domain was not located at the immediate N-terminus of Env. The ability to transduce murine cells via the ecotropic receptor varied but correlated with the amount of Env proteins incorporated into the virions. Chimeric vector particles could bind to EGFR, demonstrating the functional exposure of the peptide ligand. However, transduction of human cells expressing EGFR but not the ecotropic receptor by virions carrying the chimeric protein was not observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441077     DOI: 10.1006/viro.2002.1517

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.513


  5 in total

1.  Construction of a gammaretrovirus with a novel tropism and wild-type replication kinetics capable of using human APJ as entry receptor.

Authors:  Shervin Bahrami; Kristina Pagh; Ditte Ejegod; Mogens Duch; Martin Tolstrup; Finn Skou Pedersen
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

2.  Change of tropism of SL3-2 murine leukemia virus, using random mutational libraries.

Authors:  Shervin Bahrami; Mogens Duch; Finn Skou Pedersen
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

3.  Retargeting of viruses to generate oncolytic agents.

Authors:  M H Verheije; P J M Rottier
Journal:  Adv Virol       Date:  2011-11-14

4.  Vaccinia virus replication is not affected by APOBEC3 family members.

Authors:  Melanie Kremer; Yasemin Suezer; Yolanda Martinez-Fernandez; Carsten Münk; Gerd Sutter; Barbara S Schnierle
Journal:  Virol J       Date:  2006-10-19       Impact factor: 4.099

5.  Murine leukemia virus (MLV) replication monitored with fluorescent proteins.

Authors:  Katja Sliva; Otto Erlwein; Alexandra Bittner; Barbara S Schnierle
Journal:  Virol J       Date:  2004-12-20       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.